OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹41 Cr | ₹68 Cr | ₹58 Cr | ₹54 Cr |
What is the latest Total Non-Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹58 Cr |
| Mar2021 | ₹54 Cr |
How is Total Non-Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | -71.15 | |
| Mar2024 | ₹41 Cr | -39.49 | |
| Mar2023 | ₹68 Cr | 17.02 | |
| Mar2022 | ₹58 Cr | 6.16 | |
| Mar2021 | ₹54 Cr | - | |
Compare Total Non-Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹185.9 Cr | 1.3% | -13.1% | -49.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹429,145.0 Cr | -0.1% | -2.5% | 6.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,989.0 Cr | -0.2% | -2.8% | 1.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,322.0 Cr | 2.3% | 1.2% | 41.1% | Stock Analytics | |
| CIPLA | ₹112,149.0 Cr | 0.7% | 1.9% | -4.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,483.0 Cr | 0.1% | -2.4% | 2.3% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | 1.3% |
-13.1% |
-49.4% |
| SENSEX | -1% |
-5.7% |
-9.7% |
You may also like the below Video Courses